Eva L Feldman, MD, PhD
Neurology
109 Zina Pitcher Place, 5017 AAT-BSRB
Ann Arbor, MI 48109
Manage Your Profile
About
Dr. Feldman is one of the world’s leading authorities on neurodegenerative disease. Currently, she serves as the University of Michigan James W. Albers Distinguished University Professor and the Russell N. DeJong Professor of Neurology at Michigan Medicine. She is also the Director of the NeuroNetwork for Emerging Therapies and Scott Pranger ALS Center at Michigan Medicine.
Feldman has made contributions to biomedical research and clinical care in many critical areas of neurodegenerative disease. Her primary focus has been on amyotrophic lateral sclerosis (ALS), Alzheimer's disease, cognitive decline, and the neurologic complications of diabetes and obesity, as well as how environmental toxins affect the nervous system. She also has conducted pioneering research on developing stem cell therapies to treat these diseases.
Dr. Feldman is actively committed to and involved in professional service. She served as President of the Peripheral Nerve Society from 2007-2009 and President of the American Neurological Association (ANA) from 2011-2013. Dr. Feldman is on the National Research Council, the operating arm of the National Academies of Science, Engineering, and Medicine, and is an elected member of the National Academy of Medicine (NAM) and Association of American Physicians, and a Fellow of the American Association for the Advancement of Science. Dr. Feldman is the Editor of the Contemporary Neurology Series and also serves on a number of editorial boards for leading scientific journals, including The Lancet Neurology, Nature Reviews Neurology, JAMA Neurology and Journal of Neurology, Neurosurgery and Psychiatry.
Links
Feldman Laboratory linkedin twitter
Qualifications
-
FellowUniversity of Michigan, Neuromuscular Disorders, Ann Arbor, United States
1987 - 1998
Postdoctoral Fellowship
-
ResidencyJohns Hopkins Hospital, Neurology, Baltimore, United States
1984 - 1987
Residency
-
Chief ResidentJohns Hopkins, Neurology, Baltimore, United States
1986 - 1987
Chief Resident
-
InternshipWilliam Beaumont Hospital, Internal Medicine, Royal Oak, United States
1983 - 1984
Internship
-
MD, MedicineUniversity of Michigan Medical School, Ann Arbor, United States
1983
-
PhD, NeuroscienceUniversity of Michigan Medical School, Ann Arbor, USA
1979
-
MS, ZoologyUniversity of Notre Dame, South Bend, Indiana, United States
1973 - 1975
-
BA, Biology and ChemistryEarlham College, Richmond, Indiana, United States
1969 - 1973
Center Memberships
-
Center Membere-Health and Artificial Intelligence Initiative
-
Center MemberCenter for Cell Plasticity and Organ Design
-
Center MemberBiosciences Initiative
-
Center MemberGlobal REACH
-
Center MemberFrankel Institute for Heart and Brain Health
-
Center MemberCaswell Diabetes Institute
-
Center MemberCenter for Global Health Equity
-
Center MemberTaubman Institute
-
Center MemberCenter for Computational Medicine and Bioinformatics
Research Overview
Diabetes and obesity complications
Peripheral neuropathy
Cognitive decline
Alzheimer's disease
Amyotrophic lateral sclerosis (ALS)
Recent Publications
-
Guo K, Figueroa-Romero C, Noureldein MH, Murdock BJ, Savelieff MG, Hur J, Goutman SA, Feldman EL. Brain, 2024 Feb 1; 147 (2): 665 - 679.Proceeding / Abstract / PosterGut microbiome correlates with plasma lipids in amyotrophic lateral sclerosis
DOI:10.1093/brain/awad306 PMID: 37721161 -
Goutman SA, Savelieff MG, Jang DG, Hur J, Feldman EL. Nature Reviews Neurology, 2023 Oct 1; 19 (10): 617 - 634.Journal ArticleThe amyotrophic lateral sclerosis exposome: recent advances and future directions
DOI:10.1038/s41582-023-00867-2 PMID: 37709948 -
Eid SA, Rumora AE, Beirowski B, Bennett DL, Hur J, Savelieff MG, Feldman EL. Neuron, 2023 Sep 6; 111 (17): 2623 - 2641.Journal ArticleNew perspectives in diabetic neuropathy
DOI:10.1016/j.neuron.2023.05.003 PMID: 37263266 -
Eid SA, Noureldein M, Kim B, Hinder LM, Mendelson FE, Hayes JM, Hur J, Feldman EL. Journal of Neurochemistry, 2023 Jul 1; 166 (2): 367 - 388.Journal ArticleSingle-cell RNA-seq uncovers novel metabolic functions of Schwann cells beyond myelination
DOI:10.1111/jnc.15877 PMID: 37328915 -
Henn RE, Guo K, Elzinga SE, Noureldein MH, Mendelson FE, Hayes JM, Rigan DM, Savelieff MG, Hur J, Feldman EL. Iscience, 2023 Mar 17; 26 (3):Journal ArticleSingle-cell RNA sequencing identifies hippocampal microglial dysregulation in diet-induced obesity
DOI:10.1016/j.isci.2023.106164 -
Feldman EL, Goutman SA, Petri S, Mazzini L, Savelieff MG, Shaw PJ, Sobue G. Lancet, 2022 Oct 15; 400 (10360): 1363 - 1380.Journal ArticleAmyotrophic lateral sclerosis
DOI:10.1016/S0140-6736(22)01272-7 PMID: 36116464 -
Elafros MA, Andersen H, Bennett DL, Savelieff MG, Viswanathan V, Callaghan BC, Feldman EL. Lancet Neurology, 2022 Oct 1; 21 (10): 922 - 936.Journal ArticleTowards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments
DOI:10.1016/S1474-4422(22)00188-0 PMID: 36115364 -
Goutman SA, Hardiman O, Al-Chalabi A, Chio A, Savelieff MG, Kiernan MC, Feldman EL. Lancet Neurol, 2022 Mar 1; 21(5):: 465 - 579.Journal ArticleEmerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis
Featured News & Stories
Dr. Feldman re-elected to National Academy of Medicine Council
How ALS affects neutrophils
Lessons from the Blue Zones
Diabetic neuropathy linked with dementia and stroke
Dr. Eva Feldman featured in National Geographic
